| |
Inhalt: |
| |
|
| |
I. Bericht des International Dry
Eye WorkShop (DEWS)
|
| |
|
Inhalt |
| |
|
Leitartikel |
| |
|
Einleitung |
| |
|
Mitglieder |
| |
|
Glossar |
| |
|
Definition
und Klassifikation des Trockenen Auges |
| |
|
Epidemiologie
des Trockenen Auges |
| |
|
Methoden
zur Diagnose und zum Monitoring des Trockenen Auges |
| |
|
Design
und Durchführung klinischer Studien |
| |
|
Management
und Therapie des Trockenen Auges |
| |
|
Forschung
am Trockenen Auge |
| |
|
Bericht Index |
| |
|
Offenlegungen
von finanziellen eigentumsrechtlichen Beziehungen |
| |
|
| |
II. Das folgende zusätzliche DEWS-Material
ist elektronisch auf Englisch verfügbar: |
| |
|
| |
|
A. Definition and Classification Subcommittee
Membership |
| |
|
Goals
for the Definition and Classification Subcommittee |
| |
|
|
| |
|
B. Epidemiology Subcommittee |
| |
|
Membership |
| |
|
Goals
of the Epidemiology Subcommittee |
| |
|
Diagnostic templates (See Diagnostic Subcommittee
for complete set of templates) |
| |
|
 McCarty
symptoms questionnaire |
| |
|
Ocular
Surface Disease Index (OSDI) |
| |
|
Schein
questionnaire |
| |
|
McMonnies
questionnaire |
| |
|
IDEEL
questionnaire |
| |
|
|
| |
|
C. Diagnostic Subcommittee |
| |
|
Membership |
| |
|
Goals
of the Diagnostic Subcommittee |
| |
|
Alphabetical
listing of tests used to diagnose and monitor dry eye. |
| |
|
Functional
groupings of tests used in assessment of dry eye |
| |
|
| |
Diagnostic
templates |
| |
|
1 Letter
of invitation to rapporteurs |
| |
|
2
Pro forma template |
| |
|
3
Allergy: Brush cytology for eosinophils (Shimazaki) |
| |
|
4
Allergy: Conjunctival Provocation Test. (Shimazaki) |
| |
|
5
Allergy: Tear IgE measurement. (Shimazaki) |
| |
|
6
Basal tear volume – Periotron (Bron) |
| |
|
7
Blink: Forceful blink test with tear film interferometry (Korb) |
| |
|
8
Brush cytology technique (Tsubota) |
| |
|
9
Bulbar conjunctival hyperaemia scales (Fonn) |
| |
|
10
Evaluation of conjunctivochalasis (Yokoi) |
| |
|
11
Endocrine markers in the diagnosis of dry eye syndromes |
| |
|
12
Ferning: Tear ferning test [TFT] (Rolando) |
| |
|
13
Flow cytometry in impression cytology (Baudouin) |
| |
|
14
Fluorophotometry (Asbell) |
| |
|
15
Functional visual acuity (FVA) test (Goto) |
| |
|
16
Impression cytology, conjunctival (Nelson) |
| |
|
17
Interferometry: Tear film lipid interferometry (Yokoi) |
| |
|
18
Lacrimal gland: Salivary and lacrimal gland biopsy (Toda) |
| |
|
19
LASIK-induced neurotrophic epitheliopathy [LINE] (Wilson) |
| |
|
20
Levels of evidence, Oxford (Bron) |
| |
|
21
Lid margin disease: Criteria for classification of gland or lid margin disease
(McCulley) |
| |
|
22
Meibography (Bron; Mathers version)
|
| |
|
23
Meibography (Bron; Pflugfelder version)
|
| |
|
24
Meibography (Bron; Shimazaki version)
|
| |
|
25
Meibography/Meiboscopy (Foulks)
|
| |
|
26
Meibography (Mathers) |
| |
|
27
Meibometry (Tiffany) |
| |
|
28
Meibomian lipid chemistry (McCulley)
|
| |
|
29
Meibomian gland expression (Mathers)
|
| |
|
30
Microbiological contribution to meibomian performance (McCulley)
|
| |
|
31
Mixed tests: Schirmer-1 test without anesthesia (Bron; Vitale version)
|
| |
|
32
Mixed tests for dry eye (Bron; Afonso version) |
| |
|
33
Mixed tests: Schirmer I test without anaesthesia (Bron; Bjerrum version)
|
| |
|
34
Mixed tests (Bron; Nichols version) |
| |
|
35
Mixed tests (Bron; Pflugfelder version) |
| |
|
36
Mixed tests (Bron; Shimazaki version) |
| |
|
38
Non-Invasive Break-Up Time [NIBUT] (Bron) |
| |
|
39
Ocular Protection Index[(OPI] (Abelson, Ousler) |
| |
|
40
Osmolarity: Tear osmolarity, freezing point depression (Lemp) |
| |
|
41
Osmolarity: Tear osmolarity, OcuSense (Lemp) |
| |
|
42
Osmolarity: Tear osmolarity, Vapor pressure osmometry (Lemp) |
| |
|
43
Osmolarity: Hamano (Phenol red thread) Test (Dogru) |
| |
|
44
Questionnaire: DEQ questionnaire (Caffery) |
| |
|
45
Questionnaire: Impact of Dry Eye on Daily Life (IDEEL) questionnaire (Begley)
|
| |
|
46
Questionnaire: McCarty Symptom Questionnaire (Caffery) |
| |
|
47
Questionnaire: McMonnies questionnaire (Caffery) |
| |
|
48
Questionnaire: NEI-VFQ 25 Quality of Life Questionnaire (Caffery) |
| |
|
49
Questionnaire: OSDI: Ocular Surface Disease Index (Caffery) |
| |
|
50
Questionnaire: Schein Questionnaire (Caffery) |
| |
|
51
Questionnaire: Medical Outcomes Study Short Form-36 Health Survey (SF-36)
(Begley) |
| |
|
52
Questionnaire: EQ-5D (Begley)
|
| |
|
53
Questionnaire: Sicca Symptoms Inventory (Bowman)
|
| |
|
54
Rheumatic disease: Criteria for rheumatic diseases (Bron)
|
| |
|
55
Schirmer I test without anesthesia. (Bron: Nichols version)
|
| |
|
56
Schirmer I test without anesthesia. (Bron: Farris version)
|
| |
|
57
Schirmer-1 Test without anesthesia (Bron: van Bijsterveld version)
|
| |
|
58
Schirmer-1 Test without anesthesia (Bron: Vitale version)
|
| |
|
59
Schirmer 1 without anesthesia (Bron: Pfugfelder version)
|
| |
|
60
Schirmer I test without anesthesia. (Bron: Afonson version)
|
| |
|
61
Selected collected sensitivity and specificity data for dry eye tests
|
| |
|
62
Sequence of tests: preferred sequence (Bron)
|
| |
|
63
Sjogren syndrome; Direct sialometry (Murube)
|
| |
|
64
Sjogren syndrome: Salivary scintigraphy (Murube)
|
| |
|
65
Sjogren syndrome: Sialography (Murube)
|
| |
|
66
Sjogren syndrome: Mathematical model for SS diagnosis (Bron)
|
| |
|
67
Sjogren syndrome: Hematological tests for Sjogren syndrome (Murube)
|
| |
|
68
Staining: grading: van Bijsterveld schema (Bron)
|
| |
|
69
Staining, grading: CLEK Schema (Bron)
|
| |
|
70
Staining: CLEK staining examination form
|
| |
|
71
Staining: grading: Oxford Schema (Bron)
|
| |
|
72
Tear evaporation test (Tsubota, Goto)
|
| |
|
73
Tear evaporation test (Tsubota)
|
| |
|
74
Tear film: Symptomatic Tear Film Break-Up Time [SBUT] (Abelson, Ousler)
|
| |
|
75
Tear film breakup dynamics [TBUD] tests (Begley)
|
| |
|
76
Tear film breakup [TFBUT] (Abelson, Ousler)
|
| |
|
77
Tear film lipid layer interferometry (Goto)
|
| |
|
78
Tear flow --fluorophotometry (fluorimetry) tear flow (Tomlinson)
|
| |
|
79
Tear function index [Liverpool modification] (Kaye)
|
| |
|
80
Tear Function Index (Toda)
|
| |
|
81
Tear meniscus height and cross-sectional area (Willcox)
|
| |
|
82
Tear meniscus: Reflective meniscometry (Yokoi)
|
| |
|
83
Strip meniscometry (Dogru)
|
| |
|
84
Tear protein profiles (Grus)
|
| |
|
85
Tear proteins other than lactoferrin – tear protein profiles (Willcox)
|
| |
|
86
Tear proteins [especially lactoferrin] analysis (Willcox)
|
| |
|
87
Tear proteins other than lactoferrin – lipocalin (Willcox)
|
| |
|
88
Tear turnover: Fluorimetry (Tomlinson)
|
| |
|
89
Tear volume: Fluorimetry (Tomlinson)
|
| |
|
90
Tear Stability Analysis System (TSAS) (Dogru)
|
| |
|
91
Thermography: Aqueous tear deficiency (ATD). (Efron)
|
| |
|
|
| |
D. Clinical Trials Subcommittee |
| |
|
|
| |
|
Membership |
| |
|
Goals
and Objectives |
| |
|
Outline
of a manual of procedures |
| |
|
Guidelines
for Good Clinical Practices |
| |
|
Writing
the investigator’s brochure for the tested drug |
| |
|
Using
the investigational medicinal product |
| |
|
Adverse
Events and Management Issues |
| |
|
|
| |
E. Management and Therapy Subcommittee |
| |
|
|
| |
|
Membership |
| |
|
Goals |
| |
|
|
| |
F. Research Subcommittee |
| |
|
|
| |
|
Membership |
| |
|
Goals
of the Research Subcommittee |
| |
|
DEWS
research committee report form |
| |
|
|
| |
G. |
Industry Liaison Subcommitee |
| |
|
|
| |
|
Membership |
| |
|
Function |
| |
|
|
| |
H. |
Communications Subcommittees |
| |
|
|
| |
|
Membership |
| |
|
Goals |
| |
|
|